A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 as Well as the Impact of AZD4144 on the Pharmacokinetics of Rosuvastatin and Furosemide in Healthy Participants

NCT06491550 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: AZD4144- Part A
DRUG: Placebo- Part A
DRUG: AZD4144- Part B
DRUG: Placebo- Part B
DRUG: Rosuvastatin and Furosemide- Part C
DRUG: Rosuvastatin, Furosemide, and AZD4144 Part C

Sponsor

AstraZeneca